372 filings
Page 9 of 19
5
7hwk9p2c9x6ejvlv
2 Feb 22
Krystal Biotech / DANIEL JANNEY ownership change
4:38pm
4
cq08j h8i6
31 Jan 22
Krystal Biotech / Jing L. Marantz ownership change
5:27pm
4
gt0q1c4w3ldfnen7ncv
31 Jan 22
Krystal Biotech / Everett Rand Sutherland ownership change
4:47pm
3
sz0fwdj
26 Jan 22
Krystal Biotech / Everett Rand Sutherland ownership change
4:56pm
8-K
rtj5n3s00qkygxb95
18 Jan 22
Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, MD, MPH to its Board of Directors
4:06pm
4
ke5u3b j2
14 Dec 21
Krystal Biotech / Suma Krishnan ownership change
4:14pm
4
o3vkwiw6idkm3o79mt
14 Dec 21
Krystal Biotech / DANIEL JANNEY ownership change
4:11pm
4
ibft7nxpkl7nlvm
14 Dec 21
Krystal Biotech / Krish S Krishnan ownership change
4:09pm
SC 13G
tbwx7yyy1zjah5su8
6 Dec 21
Krystal Biotech / Point72 Asset Management ownership change
5:22pm
8-K
c5o muhl0e3b3y
3 Dec 21
Entry into a Material Definitive Agreement
4:05pm
424B2
0yfrqcaavxxawwbrwa9b
1 Dec 21
Prospectus for primary offering
5:27pm
424B5
e883 m2a61jz63ve
29 Nov 21
Prospectus supplement for primary offering
4:54pm
8-K
ebjp z0sa
29 Nov 21
Krystal Biotech Announces Positive Topline Results from GEM-3 Pivotal Trial of
4:06pm
8-K
ctc9v56f y3tr2bgv
8 Nov 21
Krystal Biotech Reports Third Quarter 2021 Financial Results and Provides Update on Operational Progress
4:43pm
8-K
u3onn xwtg
16 Sep 21
Entry into a Material Definitive Agreement
4:33pm
8-K/A
dhkckntj5nx
19 Aug 21
Regulation FD Disclosure
4:49pm
8-K
imhlu ekjx
9 Aug 21
Krystal Biotech Reports Second Quarter 2021 Financial Results and Provides Update on Operational Progress
4:02pm
8-K
xdvmgw mjeu3r19xrpfw
2 Aug 21
Jeune Aesthetics Announces Initiation of Dosing in Efficacy Cohort of KB301 Phase
4:39pm